IBX vs NEU

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

IBX

IMAGIONBIO FPO [IBX]

28LOW

NEU

NEUREN FPO NZ [NEU]

47LOW

Score Breakdown

IBX NEU
Technical
35
61
Catalyst
53
50
Sentiment
50
50
Fundamental
17
62
Momentum
25
26
Risk Gate
27
43

Key Metrics

IBX Metric NEU
$6.5MMarket Cap$2.1B
2.6MAvg Volume (20d)725K
N/AShort Interest+4.9%
$0.05552-Week High$22.985
$0.01152-Week Low$11.000
+0.0%Daily Change+0.2%
$0.011Reference Price$16.530
N/AROE+8.7%
N/AProfit Margin+47.1%

Active Signals

IBX Signals

●RSI drifting toward oversold territory — worth watching
●MACD momentum is losing steam
●Stochastic is deep in oversold territory — bounce conditions forming
●Trading below both moving averages — the trend is working against this one
●Above-average volume (1.8x) on a red day — sellers in control
●Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
●Sitting near support — this level has held before and could attract buyers again
●Took a hit — down 15.4% over the last 5 days

NEU Signals

●Beating the Small Ords index — relative strength of 1.37, so it's outpacing the pack
●Trading above the 200-day average — the long-term trend is on your side
●Cash positive / operating cashflow positive
●Revenue in sharp decline (-81%)
●Piotroski F-Score strong (7/9, low-confidence approx)
●EPS estimates revised upward (+10pts)
●Post-earnings drift: negative surprise (SUE -10)
●Earnings in sharp decline (-88% QoQ)

Ask Scout AI to compare IBX and NEU in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

IBX vs PHX →IBX vs PYC →IBX vs RCE →IBX vs RHY →IBX vs TRI →
IBX Full Analysis → NEU Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).